Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics

AI Briefing

• – Roche to acquire PathAI, expanding its presence in digital pathology and AI-powered diagnostics.
• – The acquisition builds on the successful partnership established in 2021 and will create AI-enabled companion diagnostic algorithms.
• – The transaction is expected to close in the second half of the year.